Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome b5 reductase-like (CYB5RL) is a human protein belonging to the oxidoreductase family, showing sequence similarity to bona fide cytochrome b5 reductases. These enzymes transfer electrons from NADH or NADPH to cytochrome b5 and other substrates, participating in redox reactions critical for lipid metabolism, cholesterol biosynthesis, and erythrocyte methemoglobin reduction. CYB5RL is predicted to possess cytochrome-b5 reductase activity and may function in electron transfer and bicarbonate transport, but its biological roles are only partially characterized. Disease associations include sulfhemoglobinemia and a congenital syndrome, though there is minimal evidence for direct drug interactions or biomarker utility at present.
Not established for CYB5RL specifically; for cytochrome b5 reductase family, mechanisms typically involve electron transfer from NADH/NADPH to facilitate reduction reactions, often with cytochrome b5 as the acceptor
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome b5 reductase-like (CYB5RL).